NEU1 Antikörper

Produktnummer ABIN958820

Der Kaninchen Polyklonal Anti-NEU1-Antikörper wurde für WB, IHC und IF validiert. Er ist geeignet, NEU1 in Proben von Arthrobacterium ureafaciens (A. ureafaciens) zu detektieren.

Kurzübersicht für NEU1 Antikörper (ABIN958820)

Target: NEU1 (Sialidase 1 (Lysosomal Sialidase) (NEU1))

Reaktivität: Arthrobacterium ureafaciens (A. ureafaciens)

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser NEU1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)

Produktdetails anti-NEU1 Antikörper

Spezifität: Arthrobacterium ureafaciens Neuraminidase. The reagents were evaluated for potency, purity and specificity using most or all of the following techniques: immunoelectrophoresis, cross-immunoelectrophoresis, single radial immunodiffusion (Ouchterlony), block titration, ELISA, immunoblotting and enzyme inhibition. Cross-reactivity Cross-reactivities against enzymes of other sources may occur but have not been determined.

Aufreinigung: Ion exchange chromatography

Immunogen: Arthrobacterium ureafaciens Neuraminidase

Type of Immunogen: Purified protein

Anwendungsinformationen

Applikationshinweise: Approved: IF, IHC, WB

Usage: This product is intended for use in precipitating and non-precipitating antibody-binding assays (such as e. g., Western blotting and immunofluorescence or histochemical techniques), to prepare an insoluble immunoaffinity adsorbent, for labeling with a marker of the customer's own choice.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Sterile distilled water 1 ml

Konzentration: Lot specific

Buffer: Lyophilized from PBS, pH 7.2

Handhabung: Avoid repeat freeze-thaw cycles.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Long term: -20°C
Short term: +4°C. Avoid repeat freeze-thaw cycles.

Details zu NEU1

Target: NEU1 (Sialidase 1 (Lysosomal Sialidase) (NEU1))

Andere Bezeichnung: Neuraminidase

Substanzklasse: Influenza Protein

Pathways: SARS-CoV-2 Protein Interaktom